SCHEMBL23722341

SCHEMBL23722341

C[C@H](C=O)C[C@@H]1CCNC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24235431 0.83 PTGER3 (0.35)
SCHEMBL6732243 0.81 AR (0.44)
SCHEMBL24235351 0.79
SCHEMBL25264535 0.79
SCHEMBL23721419 0.79
SCHEMBL25264534 0.79
SCHEMBL24235515 0.78
SCHEMBL25134614 0.78 PTGER3 (0.35)
SCHEMBL25006853 0.76 PTGER3 (0.34)
SCHEMBL24113100 0.75 PTGER3 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11859014-B2 Peptidomimetics for the treatment of Norovirus infection EMORY UNIVERSITY (US) 2024-01-02 US disclosed
WO-2023055702-A1 MAIN PROTEASE (M PRO) INHIBITORS AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2023-04-06 WO disclosed
WO-2022268111-A1 ANTIVIRAL PHARMACEUTICAL COMPOSITION, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 前沿生物药业(南京)股份有限公司 2022-12-29 WO disclosed
WO-2021151265-A1 PHARMACEUTICAL USE OF ALDEHYDE-BASED COMPOUND 中国科学院上海药物研究所 2021-08-05 WO disclosed